Tokyo and Mainz, Germany (ots/PRNewswire) - - Acquisition Would Expand Astellas' Oncology Pipeline with Antibody in Late-Stage - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ganymed Pharmaceuticals AG (CEO; Özlem Türeci, "Ganymed"), a biopharmaceutical company located in Mainz, Germany which focuses on the development of antibodies against cancer, announced today that Astellas ...
Nuremberg, Germany (ots/PRNewswire) - Internationally, the top five physical conditions that people worry most about having, either now or as they age, are eyesight getting poorer, not being as mentally alert, lacking energy, having trouble taking care of themselves physically, and being unable to walk or drive. These are the findings from a GfK survey (http://www.gfk.com/global-studies/global-study-overview/) of the ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Grant established by Merck KGaA, Darmstadt, Germany, recognizes pioneering research in personalized treatment of solid tumors - Winners selected by internationally renowned oncologists from 405 applications representing 49 countries Merck KGaA, ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or UK-based media - Grant established by Merck recognizes pioneering research in personalized treatment of solid tumors - Winners selected by internationally renowned oncologists from 405 applications representing 49 countries Merck, a leading science and technology company, today announced the recipients of ...
Nuremberg, Germany (ots/PRNewswire) - A recent international GfK survey (http://www.gfk.com/global-studies/global-study-overview/), conducted online in 16 countries, shows one in three people (33 percent) currently monitor or track their health or fitness via an online or mobile application, or via a fitness band, clip, or smartwatch. China is well in the lead for ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media ESMO Abstract # Avelumab: 777PD, 7775PD, 1154P, 842TiP, 844TiP; Erbitux: 527P, 491P, 967P, 994P; Tepotinib: 1257P, 1287TiP, 1292TiP - Merck KGaA, Darmstadt, Germany, to feature new research from marketed and pipeline compounds - Preliminary results from combination study with avelumab in renal cell ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media ESMO Abstract # Avelumab: 777PD, 775PD, 1154P, 842TiP, 844TiP; Erbitux: 527P, 491P, 967P, 994P; Tepotinib: 1257P, 1287TiP, 1292TiP - Merck to feature new research from marketed and pipeline compounds - Preliminary results from combination study with avelumab in renal cell carcinoma, and ...
Darmstadt, Germany (ots/PRNewswire) - - New partnership under Healthy Women, Healthy Economies initiative facilitates women to overcome health barriers to economic participation Merck, a leading science and technology company, today announced its partnership with the Royal Health Awareness Society (RHAS) of Jordan to advance health awareness and education particularly ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Phase III studies highlight lasting reductions in relapse rates for an additional two years following short oral treatment courses in year one & year two with Cladribine Tablets Merck, a leading science and technology company, announced they ...
Darmstadt, Germany (ots/PRNewswire) - - Four research grants awarded out of 260 proposals from 45 countries Merck, a leading science and technology company, today announced recipients of the fourth annual Grant for Multiple Sclerosis Innovation (GMSI) during a symposium at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Munich, Germany (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today presented data showing the odds of reaching fasting plasma glucose (FPG) targets without hypoglycaemia and weight gain were significantly ...
Darmstadt, Germany (ots/PRNewswire) - - Two oral presentations and nine posters include new analyses on investigational Cladribine Tablets - Real-world data assess the safety, tolerability and effectiveness of Rebif® - Symposium highlights unmet needs among patients with MS and real-word issues - Grant for Multiple ...
Nuremberg, Germany (ots/PRNewswire) - - International findings show top five countries most interested in each area of home improvement When it comes to what aspect of their home people would most like to improve, the most popular answers among the online population across 22 countries are the interior décor or design (39 percent), the overall size or layout (38 ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Liquid biopsy RAS biomarker test based upon AmoyDx's real-time PCR technology, ADx-SuperARMS®, will be made available in China in 2017 - Merck is the first pharmaceutical company to collaborate with multiple diagnostic providers to support liquid biopsy RAS biomarker testing worldwide ...
Nuremberg, Germany (ots/PRNewswire) - - In Brazil and Turkey that rises to over a half - Sweden, Germany and Netherlands lead for feeling safe - Women not always more safety concerned than men Close to a third (32 percent) of the online population across 21 countries firmly agree[1] they are always concerned about their safety and security, compared to ten percent who firmly indicate[1] that they are not. GfK asked over ...
Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of the investigational product Cladribine Tablets for the treatment of relapsing-remitting multiple ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media WCGC Abstract # 0-025; poster presentation, July 1, 2016, 10:35 am CEST - Phase III study shows response rate of 61.1% for patients treated with Erbitux plus FOLFOX - 31% decrease in risk of disease progression and 24% decrease in risk of ...
Nuremberg, Germany (ots/PRNewswire) - Internationally, 42 percent of the online connected population agree firmly[1] with the statement "To me, it is important to always be reachable wherever I am" - and only 11 percent firmly disagree[1]. However, four countries - Germany, Sweden, Canada and Netherlands - run counter to this trend, with more of their connected ...
Darmstadt, Germany (ots/PRNewswire) - - Agreement provides Merck with exclusive license to cognitive remediation training programs - HAPPYneuron will be available for inclusion in Merck's MSdialog platform for use with Rebif® (interferon beta-1a) Merck, a leading science and technology company, announced today that ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - BEACON CRC trial will assess efficacy of combination regime Erbitux® (cetuximab), binimetinib and encorafenib in BRAF-mutant metastatic colorectal cancer (mCRC) Merck, a leading science and technology company, jointly announced with ...
Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that clinical data on Rebif® (interferon beta-1a), the company's high-dose, high-frequency interferon beta for relapsing forms of multiple sclerosis, and Cladribine Tablets, an investigational, oral, small ...
Nuremberg, Germany (ots/PRNewswire) - - Over half of people internationally have at least one pet - Argentina, Mexico and Brazil have highest percentage of pet-owners, followed by Russia and USA - Asians are least likely to own a pet Over half (56 percent) of people internationally have at least one pet living with them, with dogs proving most popular in Latin America, while Russian and French pet-owners prefer cats. This ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media ASCO Abstract # Avelumab: 4009, TPS4134, TPS4135, 9036, TPS9105, 3055, TPS3106, 8503, 4514, 4516, 5533, TPS5600, TPS4580, 9508; tepotinib: 4072 - Abstracts featuring Merck compounds span a broad range of cancers, with an emphasis on those which are difficult-to-treat and represent ...
Nuremberg, Germany (ots/PRNewswire) - Hong Kong and North America have the world's most highly connected consumers - but people in the United Arab Emirates are closing in fast. The new GfK Connected Consumer Index (http://connected-consumer.gfk.com/connected-consumer-index/) is a ranking of 78 countries and eight world regions that provides fast and direct comparison ...
Nuremberg, Germany (ots/PRNewswire) - Traditionally, the primary drivers for online shopping are seen as being consumers' desire for better price, time saving and choice, in particular access to the 'long tail'. In-store shopping, on the other hand, is seen as driven by the better experience delivered face to face ...
Nuremberg, Germany (ots/PRNewswire) - Internationally, people with a 'save now' mindset just outnumber people with a 'have fun now' mindset. GfK asked 27,000 internet users across 22 countries to say how strongly they agree or disagree with the statement "I want to enjoy life today and will worry about savings and investments later". Internationally, a third (34 percent) of online consumers say they agree - made up of 12 ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Chinese pivotal Phase III study meets its primary endpoint of increased progression-free survival in first-line treatment of patients with RAS wild-type metastatic colorectal cancer - Merck will work with relevant authorities to make ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Merck obtains CE mark certification for consumables of Gavi(TM) and Geri(TM) as well as for the embryo culture media suite Gems(TM) - Geri(TM) now incorporating innovative software module Geri(TM) Connect + Assess, allowing fertility labs enhanced control and consistency in embryo assessment - ...
Nuremberg, Germany (ots/PRNewswire) - - Consumers say companies should focus on providing good jobs, good quality products and being environmental The top three most important responsibilities for companies today, in the eyes of consumers, are proving good jobs for people, producing good quality products or services and being environmentally responsible. GfK surveyed ...
Frankfurt, Germany (ots/PRNewswire) - ABB is showcasing its latest solutions for residential and commercial buildings at the world's biggest international buildings event, Light & Building 2016 ABB, a global leader in power and automation, is demonstrating the future of homes and buildings at its 1,400 square meter exhibition space at the 2016 Light & Building event ...